These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Impact of short-term intermittent intravenous dobutamine therapy on endothelial function in patients with severe chronic heart failure. Freimark D, Feinberg MS, Matezky S, Hochberg N, Shechter M. Am Heart J; 2004 Nov; 148(5):878-82. PubMed ID: 15523321 [Abstract] [Full Text] [Related]
12. The differential effects of positive inotropic and vasodilator therapy on diastolic properties in patients with congestive cardiomyopathy. Carroll JD, Lang RM, Neumann AL, Borow KM, Rajfer SI. Circulation; 1986 Oct; 74(4):815-25. PubMed ID: 3757193 [Abstract] [Full Text] [Related]
13. Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure. Ishihara S, Gayat E, Sato N, Arrigo M, Laribi S, Legrand M, Placido R, Manivet P, Cohen-Solal A, Abraham WT, Jessup M, Mebazaa A. Clin Res Cardiol; 2016 Dec; 105(12):971-980. PubMed ID: 27314418 [Abstract] [Full Text] [Related]
14. Comparison of acute hemodynamic response to dobutamine and intravenous MDL 17,043 (enoximone) in severe congestive heart failure secondary to ischemic cardiomyopathy or idiopathic dilated cardiomyopathy. Likoff MJ, Ulrich S, Hakki A, Iskandrian AS. Am J Cardiol; 1986 Jun 01; 57(15):1328-34. PubMed ID: 2940855 [Abstract] [Full Text] [Related]
15. Low-dose dobutamine responsiveness in idiopathic dilated cardiomyopathy: relation to exercise capacity and clinical outcome. Scrutinio D, Napoli V, Passantino A, Ricci A, Lagioia R, Rizzon P. Eur Heart J; 2000 Jun 01; 21(11):927-34. PubMed ID: 10806017 [Abstract] [Full Text] [Related]
16. Dobutamine in severe scorpion envenomation: effects on standard hemodynamics, right ventricular performance, and tissue oxygenation. Elatrous S, Nouira S, Besbes-Ouanes L, Boussarsar M, Boukef R, Marghli S, Abroug F. Chest; 1999 Sep 01; 116(3):748-53. PubMed ID: 10492282 [Abstract] [Full Text] [Related]
17. Dobutamine-induced augmentation of left ventricular ejection fraction predicts survival of heart failure patients with severe non-ischaemic cardiomyopathy. Ramahi TM, Longo MD, Cadariu AR, Rohlfs K, Slade M, Carolan S, Vallejo E, Wackers FJ. Eur Heart J; 2001 May 01; 22(10):849-56. PubMed ID: 11350094 [Abstract] [Full Text] [Related]
18. Effects of low-dose flosequinan on left ventricular systolic and diastolic chamber performance. Starling MR. Am Heart J; 1994 Jul 01; 128(1):124-33. PubMed ID: 8017265 [Abstract] [Full Text] [Related]